| NCT ID | NCT07120672 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Perfusion Index |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-08 |
| Primary Completion | 2025-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-08 with a primary completion date of 2025-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the predictive role of the Peripheral Perfusion Index (PPI) in forecasting extubation success during the weaning process in intensive care unit (ICU) patients. The study will investigate the ability of PPI to predict extubation failure by comparing it with traditional weaning criteria, including the Rapid Shallow Breathing Index (RSBI), PaO₂/FiO₂ ratio, and respiratory rate.
Eligibility Criteria
Inclusion Criteria: * Patients who have been on mechanical ventilation for at least 48 hours * Patients over 18 years of age who are planned to undergo extubation following a spontaneous breathing trial (SBT) * Patients or their legal representatives who provide informed consent to participate in the study Exclusion Criteria: * Patients for whom extubation is not planned due to hemodynamic instability * Patients with peripheral vascular disease or a history of hand surgery * Patients who die or cannot be followed up during the study period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07120672 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Perfusion Index. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120672 currently recruiting?
Yes, NCT07120672 is actively recruiting participants. Contact the research team at drvdinc@gmail.com for enrollment information.
Where is the NCT07120672 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07120672 clinical trial?
NCT07120672 is sponsored by Gaziosmanpasa Research and Education Hospital. The trial plans to enroll 100 participants.